Clinical Trials Logo

Filter by:
NCT ID: NCT00260247 Completed - Clinical trials for Metabolic Clearance Rate

Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.

Start date: April 2005
Phase: Phase 4
Study type: Interventional

This is a study of the possible effect of two antiepileptic drug on enzymes in the liver that metabolizes a number of drugs. It is a well know fact that carbamazepine induces some of these enzymes and this may reduce the effect of concomitantly administered drugs. Clinical observations suggest that oxcarbazepine does not induce these enzymes to the same degree. This study directly compares the ability of these two drugs to induce the cytochrome P450 3A4 enzyme, in healthy volunteers using a well defined biomarker reaction of a specific enzyme activity. It is the hypothesis that oxcarbazepine induces CYP3A4 to a lesser degree than carbamazepine.

NCT ID: NCT00260000 Completed - Phenylketonuria Clinical Trials

Study of BH4, a New and Simple Treatment of Mild PKU

Start date: April 2005
Phase: Phase 2
Study type: Interventional

The main purpose is to test whether treatment with BH4-tablets can replace the protein restrictive diet in patients with mild PKU caused by a certain frequent mutation.

NCT ID: NCT00259779 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Comparison Between Symbicort® and Prednisolone in COPD

SPACE
Start date: September 2005
Phase: Phase 3
Study type: Interventional

To assess if Symbicort forte Turbuhaler (during two weeks) is as effective as an oral course of prednisolone + Oxis Turbuhaler (during two weeks) for the treatment of an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD).

NCT ID: NCT00259428 Completed - Atrial Fibrillation Clinical Trials

EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)

EURIDIS
Start date: November 2001
Phase: Phase 3
Study type: Interventional

To assess the efficacy of dronedarone versus placebo for the maintenance of normal sinus rhythm after electrical, pharmacological or spontaneous conversion of atrial fibrillation/atrial flutter (AF/AFL). To assess the efficacy of dronedarone versus placebo on AF/AFL-related symptoms. To assess the efficacy of dronedarone versus placebo on ventricular rate control in case of AF/AFL recurrence.

NCT ID: NCT00259259 Completed - Obesity Clinical Trials

Functional Lipids and Appetite Regulation

Start date: October 2005
Phase: N/A
Study type: Interventional

To evaluate the short-term effects of structured lipids on appetite regulation.

NCT ID: NCT00259194 Completed - Myocardial Ischemia Clinical Trials

Observation and Prediction of Complications After Coronary Angiography

OPKAT
Start date: December 2005
Phase: N/A
Study type: Interventional

Coronary angiography via the femoral artery is regarded as a safe procedure, but bleeding complications are often seen. To avoid/reduce bleeding complications digital compression is applied in the area of puncture during approximately 20 minutes and the patient is in the investigators' department observed in bed for 2 hours. The investigators apply pressure over the puncture site using a sand bag in the first hour. The patients are told not to move, to keep their legs and upper arms down and not to lift the head from the pillow in these 2 hours (standard observation). In the present study the patients are randomized between standard observation and an alternative observation, where the patients are allowed to lift their head, arms and legs during the 2 hours, otherwise as standard observation. The study has three aims: 1. To establish the incidence of bleeding complications: - Frequency of hematoma (> 5 cm) - Frequency of pseudoaneurysms - Frequency of bleeding demanding surgery - Frequency of bleeding demanding transfusion 2. Establish a model to predict in wich patient to expect a bleeding complication. 3. Assess if the alternative observation is associated with more bleeding complications compared to standard observation.

NCT ID: NCT00259168 Completed - Insulin Resistance Clinical Trials

Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?

Start date: June 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether attenuation/normalization of elevated blood sugar after meals ameliorates vessel wall (endothelial) function in individuals with insulin resistance.

NCT ID: NCT00259025 Completed - Clinical trials for Renal Failure, Chronic

Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients

Start date: September 2006
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to investigate whether intravenous infusion of a lipid emulsion with a high content of n-3 polyunsaturated fatty acids can improve heart rate variability and ventricular repolarization and reduce ventricular arrhythmias in hemodialysis patients.

NCT ID: NCT00258622 Completed - Pain Clinical Trials

NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain

Start date: November 2005
Phase: Phase 2
Study type: Interventional

Purpose: To evaluate the efficacy, tolerability and safety of NS1209 compared to lidocaine and placebo in patients with peripheral chronic neuropathic pain.

NCT ID: NCT00258557 Completed - HIV Clinical Trials

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy, safety and tolerability of TMC114/r versus Kaletra (a combination pill of lopinavir and ritonavir, ("lpv/rtv") in HIV-1 infected patients who have never been treated with anti-retroviral medications (referred to as "treatment-naïve" patients).